Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1631.65
-2.75 (-0.17%)
< Home < Back

Sun Pharma’s arm raises Rs 1,000 crore on private placement basis

Date: 24-12-2015

Sun Pharmaceutical Industries’ wholly-owned subsidiary - Sun Pharma Laboratories has raised, on private placement basis, Rs 1,000 crore by allotment of 10,000,  ‘AAA / Stable Outlook’ Rated by ICRA, Unsecured Redeemable Non-Convertible Debentures of a face value of Rs 10,00,000 each to be listed on BSE under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 39 months.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.